Zyvex And OCSiAl Terminate Acquisition Plan

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Zyvex Technologies and OCSiAl halt acquisition

COLUMBUS, Ohio, Sept. 9, 2014 /PRNewswire/ -- Zyvex Technologies and OCSiAl today announced that a previously reported acquisition has been terminated. In June, the companies announced that Zyvex was to be acquired and would operate as the Zyvex Technologies division of OCSiAl. This decision does not affect future plans for cooperation between the companies.

Zyvex Chairman Jim Von Ehr said, "When we started talking with OCSiAl earlier this year, we saw synergies in combining, but as we went along, it became apparent that we could better serve our customers and employees by remaining independent. We look forward to a continued relationship with OCSiAl across a number of areas, but as separate companies. The advanced technology and class-leading products offered by each company will continue to be independently available for commercial applications."

About Zyvex Technologies

Zyvex was founded in 1997 as the first company solely focused on nanotechnology. Zyvex successfully introduced products to a variety of industries, from semiconductors to sporting goods, and received significant acclaim for its advances in commercializing molecular nanotechnology. More information can be found at www.zyvextech.com.

About OCSiAl

OCSiAl is the creator of a leading technology for the mass industrial production of single wall carbon nanotubes, redefining the market in terms of price and quality. OCSiAl enables commercial advances in industries from lithium-ion batteries to tires and rubber, transparent conductive films, and polymer composite materials. More information can be found at www.ocsial.com.

Zyvex contact: Lance Criscuolo, President, +1 214 477 0021

OCSiAl contact: Max Atanassov, CEO, +1 415 906 5271

SOURCE Zyvex Technologies

Help employers find you! Check out all the jobs and post your resume.

Back to news